17 February 2026

In 2025, Swissmedic authorised 40 new medicinal products and 109 additional indications. Of these, 25% and 19%, respectively, were processed in connection with international procedures. Swissmedic has published a report summarising the key information on both the new authorisations and the approved additional indications.

For more information, see here.